Latest sales, operating income and net profit figures for analytical instrument and laboratory product companies
IBO Stock Indexes yearly performance mixed.
Two lab product companies go public with mixed results
Latest sales, operating income and net profit figures for analytical instrument and laboratory product companies
Overseas sales propelled quarterly revenue
IBO Stocks experience positive gains amidst volatile US stock market.
Companies thrive despite looming US-China trade dispute.
Illumina, PerkinElmer and Thermo Fisher Scientific thrive while other companies receive soft sales for the third quarter
IBO stocks dwindle as market has massive selloff
Like the overall market, the second quarter for the Life Science Instrument industry shows both current economic strength but also uncertainty for the future.
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
